Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), bought 3,000 shares at $3.28 ($10K) on 2008-11-13, disclosed to the SEC on 2008-11-13.
Open-market purchase of $10k ARRY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |